Frank A. D’Amelio

Frank A. D’Amelio served as the Executive Vice President and Chief Financial Officer of Pfizer, a research-based global biopharmaceutical company, from December 2010 until May 2022, where he was responsible for all corporate finance functions, including audit, controllership, financial planning and analysis, tax, investor relations, and treasury. From 2018 through 2021, in addition to his CFO responsibilities, Mr. D’Amelio was also responsible for Pfizer’s global supply chain, which included the manufacturing and distribution of the COVID-19 vaccine. During his time at Pfizer, he led the company through a multi-year transformation to an industry leading, science-based biopharmaceutical company. Prior to that, he served as Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent, a telecommunications equipment and services company, from November 2006 to August 2007. In addition to HPE, he also serves on the board of directors and chairs the Audit Committee of Humana, Inc. an insurance provider, and on the board of directors of Zoetis, Inc. an animal health company.

Mr. D’Amelio brings to our board of directors robust expertise and proven leadership in finance, corporate development, operations, IT, and supply chain across multiple industries.